Nano cap Precipio (PRPO +422.8%) rockets up on a whopping 61x surge in volume in reaction to its agreement with ADS Biotec to distribute its COVID-19 antibody blood test worldwide.
Precipio will initially offer the test as a service in its CLIA lab starting in August with a subsequent rollout to doctors’ offices as a point-of-care assay followed by distribution via retail channels for at-home direct-to-consumer use.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.